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Petection of Exercise-Induced
schemia by Changes in B-Type Natriuretic Peptides
obert S. Foote, MD,*† Justin D. Pearlman, MD, PHD, FACC,*†‡ Alan H. Siegel, MD,†‡
iang-Teck J. Yeo, PHD†§
ebanon and Hanover, New Hampshire
OBJECTIVES The purpose of this study was to examine the effect of exercise-induced ischemia on levels of
B-type natriuretic peptide (BNP) and its inactive N-terminal fragment (NT-pro-BNP) and
to determine whether measurement of these peptides can improve the diagnostic accuracy of
exercise testing.
BACKGROUND The ability of exercise testing to detect coronary artery disease (CAD) is limited by modest
sensitivity and specificity. B-type natriuretic peptides (NT-pro-BNP and BNP) are released
by ventricular myocytes in response to wall stress. We hypothesized that exercise-induced
ischemia results in increased wall stress and triggers release of NT-pro-BNP and BNP.
METHODS A total of 74 patients with known CAD, normal left ventricular function, and normal resting
levels of NT-pro-BNP and BNP who were referred for exercise testing with radionuclide
imaging, and 21 healthy volunteers, were enrolled. Blood was drawn before and after maximal
exercise and analyzed for NT-pro-BNP and BNP.
RESULTS Of the patients with CAD, 40 had ischemia on perfusion images and 34 did not. Median
post-exercise increases in NT-pro-BNP and BNP (NT-pro-BNP and BNP) were
approximately four-fold higher in the ischemic group than in the nonischemic group
(NT-pro-BNP 14.5 vs. 4 pg/ml, p  0.0001; BNP 36.5 vs. 7.5 pg/ml, p  0.0001). In
volunteers, median NT-pro-BNP was almost identical to that of the nonischemic patient
group. At equal specificity to the electrocardiogram (ECG) (58.8%), the sensitivities of
NT-pro-BNP and BNP for detecting ischemia were 90% and 80%, respectively; in
contrast, the sensitivity of the exercise ECG was 37.5%.
CONCLUSIONS Measurement of exercise-induced increases in BNPs more than doubles the sensitivity of the
exercise test for detecting ischemia with no loss of specificity. (J Am Coll Cardiol 2004;44:
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.08.0451980–7) © 2004 by the American College of Cardiology Foundation
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pxercise electrocardiography is the most widely used non-
nvasive method to detect the presence of coronary artery
isease (CAD); however, its usefulness is limited by rela-
ively modest sensitivity and specificity (1–3). Other more
ccurate noninvasive tests, such as exercise echocardiogra-
hy and exercise testing with radionuclide imaging, are less
idely available and considerably more expensive.
B-type natriuretic peptide (BNP) is a neurohor-
one with diuretic, vasodilatory, and renin-angiotensin-
ldosterone antagonist effects. It is secreted primarily by
ells in the ventricular wall in response to increases in wall
tress (4–6). BNP and the inactive amino-terminal frag-
ent of its prohormone (N-terminal fragment of B-type
atriuretic peptide pro-hormone [NT-pro-BNP]) (7) have
een shown to have diagnostic or prognostic value in a
ariety of left and right ventricular structural and functional
bnormalities, particularly heart failure, (4,8,9) as well as in
ystolic (10,11) and diastolic (12,13) dysfunction, unstable
ngina (14,15), acute coronary syndromes (16–18), and
yocardial infarction (19,20). In addition, two studies
21,22) have found evidence that tissue hypoxia alone may
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edical School, Hanover, New Hampshire. Grant support was received from the
itchcock Foundation (Lebanon, New Hampshire). Research support was received
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ccepted August 2, 2004.rigger release of BNP in the absence of left ventricular
ysfunction.
Exercise-induced ischemia is known to produce wall-
otion abnormalities in the affected area of the ventricle
23). We hypothesized that these wall motion abnormali-
ies, or ischemia per se, might trigger release of NT-pro-
NP and BNP and that a post-exercise increase in peptide
evels might serve as a marker of inducible ischemia in
ndividual patients and thus improve the diagnostic accuracy
f the exercise test.
ETHODS
his study was approved by the Committee for the Protec-
ion of Human Subjects of Dartmouth College and Dart-
outh Hitchcock Medical Center; written informed con-
ent was obtained from all subjects.
tudy Population. Seventy-four consecutive patients with
ocumented CAD (69 by coronary angiography, 5 by
revious abnormal myocardial perfusion imaging study) and
ormal resting levels of NT-pro-BNP and BNP (based on
5th percentiles corrected for age and gender, provided by
est manufacturers), who were referred for exercise stress
esting with single-photon emission computed tomographic
SPECT) myocardial perfusion imaging were enrolled.
atients with a history of heart failure, atrial fibrillation,
acemakers, significant valvular disease (including replace-
ent), age 80 years, echocardiographic left ventricular
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November 16 2004:1980–7 Detecting Exertional Ischemia by NT-pro-BNP and BNPjection fraction55%, or recent (2 months) infarction or
e-vascularization were excluded. Also excluded were pa-
ients taking digitalis, or whose resting electrocardiograms
ECGs) showed abnormalities that would preclude inter-
retation of exercise-induced changes, for example, left
undle-branch block, left ventricular hypertrophy, 1-mm
T-segment changes, or pre-excitation. Also enrolled were
1 healthy volunteers (mean age 21.1 years) with no history
f cardiovascular disease or other significant illness.
xercise testing/perfusion imaging. In the patients with
AD, exercise testing with myocardial perfusion imaging
as performed using a dual isotope, rest-stress protocol.
our mCi 201thallous chloride were injected, and resting
mages were acquired using a Philips Irix three-headed
amma camera (Cleveland, Ohio). Patients then underwent
ymptom-limited exercise testing on a treadmill using a
ruce protocol. Exercise was terminated for fatigue, marked
yspnea, exercise-limiting angina, 20 mm Hg decrease in
ystolic blood pressure, or 3-mm ST-segment depression.
o cases of serious arrhythmia or severe hypertension
Table 1. Clinical Characteristics
Healthy
Volunteers
(n  21)
Age (yrs) (mean  SD) 21.1  1.2
Male 8 (38)*
Ejection fraction by
echocardiography (mean)
—
History of MI 0 (0)
Previous PTCA 0 (0)
Previous CABG 0 (0)
History of hypertension 0 (0)
History of diabetes 0 (0)
History of angina 0 (0)
Current smoking 0 (0)
Former smoking 0 (0)
History of increasing lipids 0 (0)
Rx beta-blocker 0 (0)
Rx ACEI 0 (0)
Rx Ca blocker 0 (0)
Rx nitrates 0 (0)
Rx ARB 0 (0)
Rx statin 0 (0)
*Values are expressed as number of individuals, with percent
Abbreviations and Acronyms
BNP  B-type natriuretic peptide
CAD  coronary artery disease
ECG  electrocardiogram/electrocardiographic
NT-pro-BNP  N-terminal fragment of B-type
natriuretic peptide pro-hormone
SDS  summed difference score
SPECT  single-photon emission computed
tomography
SRS  summed rest score
SSS  summed stress scoreACEI  angiotensin-converting enzyme inhibitor; ARB  ang
graft surgery; MI  myocardial infarction; PTCA  percutaneousecessitating termination of exercise were observed. Ninety
econds before termination of exercise, 33 mCi of 99mtech-
etium tetrofosmin (Amersham Healthcare, Arlington
eights, Illinois) were administered, and stress images were
ubsequently acquired with ECG gating. Healthy volun-
eers underwent symptom-limited exercise testing without
yocardial perfusion imaging.
Before exercise and again at 1 min post-exercise, a venous
lood sample was collected via an indwelling 20-gauge
ntravenous cannula. Samples were placed in ethylenedia-
inetetraacetic acid anticoagulated polyethylene tubes, and
he plasma was separated, aliquoted, and frozen at 80°C
ntil analysis.
nterpretation of test results. Exercise ECGs were inter-
reted by an experienced physician unaware of the interpre-
ation of perfusion images and results of analysis of blood
amples. The ECGs were interpreted as positive for isch-
mia if they showed 1 mm horizontal or downsloping
T-segment depression at 80 ms after the J-point during
xercise or recovery. Those ECGs showing no significant
T-segment depression during exercise or recovery were
nterpreted as negative for ischemia at that level of exercise
egardless of the maximal heart rate achieved.
Radionuclide SPECT images were interpreted by an
xperienced radiologist who had no knowledge of the
linical history, exercise test data, and the results of analysis
f blood samples. Images were classified as having no
erfusion defects, fixed defects only, fixed and reversible
efects, or reversible defects only; the defects were also
haracterized by size, severity, and vascular territory. Images
ere also assessed independently of the radiologist’s inter-
retation with a computer software program (QPS, Cedars
nischemic
Group
 34)
Ischemic
Group
(n  40)
p Value vs.
Nonischemic
Group
.9  9.6 61.2  10.2 0.025†
5 (73.5) 37 (92.5) NS
64% 64% NS
8 (23.5) 22 (55.0) 0.056
9 (55.9) 24 (60.0) NS
4 (11.8) 8 (20.0) NS
8 (52.9) 22 (55.0) NS
3 (8.8) 8 (20.0) NS
3 (8.8) 11 (27.5) NS
5 (14.7) 4 (10.0) NS
0 (29.4) 8 (20.0) NS
8 (82.4) 34 (85.0) NS
4 (70.6) 26 (65.0) NS
6 (47.1) 18 (45.0) NS
0 (29.4) 12 (30.0) NS
0 (0) 5 (12.5) NS
3 (8.8) 2 (5.0) NS
3 (97.1) 36 (90.0) NS
group in parentheses. †Significant at p  0.05.No
(n
55
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iotensin receptor blocker; CABG  coronary artery bypass
transluminal coronary angioplasty; Rx  treated with.
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odel which compares acquired photon counts in each
egment to a gender-specific database of normal studies.
alues from 0 to 4 are assigned to each segment, 0 being
ormal and 4 being no counts; the total is expressed as a
ummed stress score (SSS), a summed rest score (SRS), and
summed difference score (SDS), the latter indicating the
egree of reversibility. Myocardial function was assessed
sing quantitated gated SPECT imaging.
nalysis of blood samples. Resting and post-exercise
lood samples were analyzed in batches for NT-pro-BNP
sing an electrochemoluminescent immunoassay (Roche
iagnostics, Indianapolis, Indiana) on an Elecsys 1010
utoanalyzer, and for BNP using a fluorescent point-of-care
mmunoassay (Biosite, San Diego, California). Coefficients
f variation for the assays were: NT-pro-BNP 1.3% to 2.4%
nd BNP 11.2% to 14.6 % (24). The NT-pro-BNP assays
ere repeated in a separate run at a later time.
tatistical analysis. SPSS (Chicago, Illinois), Microsoft
xcel (Redmond, Washington), Analyse-IT (Analyse-IT
oftware Ltd., Leeds, England), and GraphPad Prism 4.0
San Diego, California) statistical software were used in our
nalyses or construction of figures. For continuous variables,
he Student t test was used to compare means of values with
arametric distributions and the Mann-Whitney rank sum
est to compare medians of values with nonparametric
istribution; the chi-square test was used to compare di-
hotomous variables. All tests were two-tailed. Logistic
egression and linear binary correlations (Pearson’s correla-
ions) were performed with SPSS, which incorporated
orrection for multiple comparisons. Sensitivity, specificity,
able 3. Laboratory Results
Normal
Volunteers
(n  21)
Nonische
Group
(n  34
aseline NT-pro-BNP (pg/ml) 25 (15–35) 53.5 (28–7
-min NT-pro-BNP (pg/ml) 5 (2–9) 4 (0.5–9
aseline BNP (pg/ml) — 16.5 (9.5–3
-min BNP (pg/ml) — 7.5 (3.5–1
able 2. Exercise Testing and Gated Imaging Results
Healthy
Volunteers
(n  21)
chieved METS (mean) 17.6 2.8
aximal HR (mean) 186  7.5
aximal BP (mm Hg) 158  17.8
ate-pressure product (100) 295  33.7
chieved 85% pred. max. HR, n (%) 21 (100)
xertional chest pain, n (%) 0
ositive ECG, n (%) 0
ean ejection fraction (gated SPECT) —
uke Treadmill Score 15.2
Significant at p  0.05.
BP blood pressure; ECG electrocardiogram; HR heart rate; max.maxim
omputed tomography.alues are median (interquartile range).
BNP  B-type natriuretic peptide (carboxy-terminal active fragment; NT-pro-BNP nd other test characteristics for the exercise ECG and for
he post-exercise change in NT-pro-BNP and BNP were
alculated with Analyse-IT software, and receiver operator
haracteristic curves were constructed for the changes in
eptide levels using the same program.
ESULTS
erfusion imaging. Based on the radiologist’s blinded
nterpretation of radionuclide images, 40 of the 74 enrolled
atients were classified as having perfusion defects on stress
maging that reversed at rest (“ischemic group”); 14 (35%) of
hese patients also had fixed defects. The remaining 34
atients had no fixed or reversible defects (“nonischemic
roup”). No patient had fixed defects only. Clinical charac-
eristics of the two patient groups and healthy volunteers are
hown in Table 1; the two patient groups were comparable
n all respects except age (ischemic group mean 61.2 years,
onischemic group mean 55.9 years, p 0.025) and a trend
oward more frequent history of myocardial infarction in the
schemic group (55% vs. 23.5% in the nonischemic group, p
0.056). (Student t test was used for these and all other
omparisons of mean values.) No other significant differ-
nces were found in clinical history, previous re-
ascularization, or treatment with various commonly used
edications.
xercise testing. Table 2 summarizes the findings on
xercise testing and gated imaging. Analysis of exercise test
ata showed no significant difference between the two
atient groups in maximal exercise capacity, maximal sys-
olic blood pressure, the presence of exertional chest pain, or
p Value
(vs. Normal
Volunteers)
Ischemic
Group
(n  40)
p Value vs.
Nonischemic
Group
0.0053 120.5 (76–158) 0.0001
NS 14.5 (10.5–19.5) 0.0001
— 40.5 (24–54) 0.001
— 36.5 (15–49.5) 0.0001
Nonischemic
Group
(n  34)
Ischemic
Group
(n  40)
p Value vs.
Nonischemic
Group
10.6  3.4 11.3  3.1 NS
142.1  20.2 131.8  18.3 0.026*
179.4  25.7 171.1  22.0 NS
256  56.2 226  47.6 0.019*
22 (64.7) 16 (40) NS
7 (20.6) 8 (20) NS
14 (41.2) 15 (37.5) NS
57.8% 51.8% 0.001*
3.32 4.01 NS
ETSmetabolic equivalents; pred. predicted; SPECT single-photon emissionmic
)
4)
.5)
0.5)
7.5)N-terminal fragment of B-type natriuretic peptide pro-hormone.
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November 16 2004:1980–7 Detecting Exertional Ischemia by NT-pro-BNP and BNPuke Treadmill Score. The percentage of patients who
eveloped ECG changes characteristic of ischemia did not
iffer between the two groups (nonischemic 41.2%, isch-
mic 37.5%, p  0.99). Maximal heart rate and rate-
ressure product were higher in the nonischemic group, and
ost-exercise left ventricular ejection fraction by gated
PECT was lower in the ischemic group (51.8% vs. 57.8%,
 0.001).
aboratory analysis. Table 3 shows the results of analysis
f blood samples. Volunteer blood was analyzed for NT-
ro-BNP only, and pre-exercise (baseline) levels were nor-
al in all subjects. In the ischemic and nonischemic patient
roups, although baseline levels of NT-pro-BNP and BNP
ere within normal limits, median levels of both peptides
ere significantly higher in the ischemic group (NT-pro-
NP 120.5 vs. 53.5 pg/ml, p  0.0001; BNP 40.5 vs. 16.5
g/ml, p 0.001). (Mann-Whitney rank sum test was used
or comparison of peptide levels owing to their nonpara-
etric distribution.) Interquartile ranges showed no overlap
n NT-pro-BNP values, and only modest overlap in BNP
alues. Resting NT-pro-BNP values were lower in the
ealthy volunteers (median 25 pg/ml) than in the CAD
atient groups (p  0.0053 vs. nonischemic group), consis-
ent with their much younger age.
NT-pro-BNP and BNP increased with exercise in both
schemic and nonischemic groups, and NT-pro-BNP in-
reased in the healthy volunteers (BNP was not measured in
igure 1. (A) Change in N-terminal fragment of B-type natriuretic pept
BNP) (ranges, medians, and 25th to 75th percentiles).
Table 4. Laboratory Results in Ischemic Patien
All Patien
With Ische
(n  40
Baseline NT-pro-BNP (pg/ml) 120.5 (76–15
NT-pro-BNP (pg/ml) 14.5 (10.5–
Baseline BNP (pg/ml) 40.5 (24–54
BNP (pg/ml) 36.5 (15–49Values are medians (interquartile range).
Abbreviations as in Table 3.his group). The median incremental rise of NT-pro-BNP
NT-pro-BNP) was almost identical in the healthy vol-
nteers and in the nonischemic patient group (5 vs. 4 pg/ml,
 NS). However, the incremental rise of both peptides in
he ischemic group was significantly higher than in the
onischemic group (NT-pro-BNP: 14.5 vs. 4 pg/ml, p 
.0001; BNP: 36.5 vs. 7.5 pg/ml, p  0.0001). As with
esting levels, there was no overlap in the interquartile
anges for NT-pro-BNP and modest overlap for BNP. The
NT-pro-BNP and BNP values are shown graphically in
igures 1A and 1B.
Because 14 patients in the ischemic group were found to
ave fixed as well as reversible defects on radionuclide
mages, we conducted a subset analysis on the 26 ischemic
atients with reversible defects only. Results of this analysis
re shown in Table 4. Median resting levels of NT-pro-
NP and BNP for this subgroup were 118 pg/ml and 44
g/ml, respectively, values that did not differ significantly
rom the values for the entire ischemic group. Similarly,
edian NT-pro-BNP and BNP for this subgroup were
6 and 36 pg/ml, respectively; as with resting levels, the 
alues were not significantly different from the ischemic
roup as a whole.
etection of ischemia. To evaluate the ability of NT-
ro-BNP and BNP levels to predict the presence or
bsence of ischemia in individual patients, we constructed
eceiver operator characteristic curves for each peptide (Fig.
ro-hormone (NT-pro-BNP). (B) Change in B-type natriuretic peptide
ith and Without Fixed Defects
Patients With Reversible
Defects Only
(n  26) p Value
118 (67.5–140.5) NS
16 (10.5–18.5) NS
44 (25.5–52) NS
36 (16.5–52.5) NSts W
ts
mia
)
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s 0.836 (95% confidence interval 0.742 to 0.930), and for
NP is 0.811 (95% confidence interval 0.713 to 0.908, p 
.0001 for both). Table 5 shows the test characteristics at
elected cutoff points for NT-pro-BNP and BNP. Sen-
itivities and specificities tended to be higher for NT-pro-
NP than for BNP at comparable cutoff points. In
ddition, we compared the specificity of NT-pro-BNP in
he healthy volunteer and nonischemic groups at various
utoff points (Table 6) and found the values to be
omparable.
Analysis of the exercise ECG data showed that the
ensitivity and specificity of 1-mm horizontal or downslop-
ng ST-segment depression for the detection of ischemia
ere 37.5% and 58.8%, respectively.
tatistical analysis. Linear binary correlation analysis
Pearson’s) found that baseline peptide levels correlated
igure 2. Receiver operator characteristic curve for change in B-type
atriuretic peptide (BNP) and change in N-terminal fragment of B-type
atriuretic peptide pro-hormone (NT-pro-BNP). Diagonal line  no
iscrimination; diamonds  NT-pro-BNP; squares  BNP.
able 5. Test Characteristics of BNP and NTproBNP
Sensitivity
utoff point NT-pro-BNP (pg/ml)
5 0.900
6 0.850
7 0.825
8 0.800
utoff point BNP (pg/ml)
9 0.800
10 0.800
11 0.775
12 0.775bbreviations as in Table 3.ositively with age (r  0.57, p  0.0001), SSS (r  0.56,
 0.0001), SRS (r  0.45, p  0.0001), and SDS (r 
.50, p  0.0001), and negatively with maximal heart rate
r  0.35, p  0.002) and exercise capacity (r  0.29,
 0.01); by contrast, NT-pro-BNP and BNP corre-
ated only with SSS (r  0.35, p  0.002) and SDS (r 
.33, p 0.004), and less strongly with SRS (r 0.25, p
.03), but not with any other measured clinical or exercise
est-derived variables. Logistic regression analysis showed
hat after correcting for other variables, BNP and NT-
ro-BNP were strongly predictive of ischemia (z score 12.8,
 0.001). In a generalized linear model, peptide levels
ccurately predicted SDS values (F ratio 10.4, p  0.001).
ISCUSSION
ssociation of increased BNPs with ischemia. We
ypothesized that exercise-induced ischemia, either directly
r by causing regional wall motion abnormalities, would
esult in detectable increases in levels of BNPs. Our finding
f significantly larger post-exercise increments of NT-pro-
NP and BNP in the group of patients with inducible
schemia, compared with the group without, supports this
ypothesis.
Because the exercise-induced increments in peptide levels
n all groups were small compared with resting levels, we did
ot find percent change over baseline to be a useful
iagnostic parameter. By contrast, the absolute increases
emonstrated a strong ability to discriminate ischemic from
onischemic patients (Fig. 1, Table 5). For NT-pro-BNP,
edian absolute increases in the nonischemic group and
ealthy volunteers were 4 and 5 pg/ml, respectively (p 
S), whereas in the ischemic group NT-pro-BNP was
ver threefold higher (14.5 pg/ml, p  0.0001 vs. nonisch-
mic group). Similarly, absolute BNP in the ischemic
roup was over four-fold higher than in the nonischemic
roup (36.5 vs. 7.5 pg/ml, p  0.0001).
Of particular note is that the median absolute NT-pro-
NP in the nonischemic patient group was almost identical
o that of the healthy volunteers (4 vs. 5 pg/ml, p  NS),
espite marked differences in age, exercise capacity, maximal
ificity
Diagnostic
Accuracy
Positive
Likelihood
Ratio
Negative
Likelihood
Ratio
588 0.757 2.19 0.170
706 0.773 2.89 0.213
706 0.770 2.81 0.248
735 0.770 3.02 0.272
559 0.689 1.81 0.358
588 0.703 1.94 0.340
618 0.703 2.03 0.364
647 0.716 2.20 0.348Spec
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November 16 2004:1980–7 Detecting Exertional Ischemia by NT-pro-BNP and BNPeart rates, and resting NT-pro-BNP levels in the nonisch-
mic patients that were more than twice as high as those of
he volunteers. This suggests that the higher  peptide
evels in ischemic patients compared with nonischemic
atients were not due to the slightly higher age or to the
igher baseline peptide levels in the ischemic group. The
igher  peptide levels in the ischemic group are also
nlikely to be the result of the presence within this group of
atients with previous myocardial infarction, because our
ubset analysis in which we excluded results of all patients
ith fixed perfusion defects on perfusion imaging showed
esults no different from the group as a whole (Table 4).
eanalyzing blood samples of all subjects for baseline and
NT-pro-BNP values in a separate duplicate assay also did
ot significantly alter the results or the receiver operator
haracteristic curve of NT-pro-BNP. This is consistent
ith the low coefficient of variation for this assay.
A recent study by Wu et al. (25) of a small number of
pparently healthy subjects examined percent intra-
ndividual biologic variation in natriuretic peptide levels
ver eight weeks and found changes of 33.3% for NT-pro-
NP and 43.6% for BNP. In our study, blood samples were
rawn at most a few minutes apart, with interval exercise
eing the only intervention, thus it is unlikely that the
bserved differences are the result of intra-individual varia-
ion over time. McNairy et al. (26) measured BNP levels
re-exercise and immediately post-exercise in a small group
f normal subjects and found a median 55% increase in
ost-exercise levels, with a return to baseline levels (0.9%)
y 60 min post-exercise. This is consistent with the changes
n BNP observed in our nonischemic patients (median
5.4% increase). We also measured NT-pro-BNP levels at
ntervals up to 1 h post-exercise and found minimal differ-
nces from baseline levels by 30 to 60 min (data not shown).
urthermore, our ischemic group showed a median 1-min
ost-exercise increase in BNP almost twice as high as the
onischemic group (85.7% vs. 45.4%). Earlier studies
27–29) have also shown evidence of larger increases in
NP in patients with evidence of inducible ischemia,
ompared with nonischemic patients. As noted earlier, we
ound absolute increases, rather than percent increases, to
ave much higher discriminatory power.
Although there was no difference in ejection fraction by
chocardiography before study entrance between the two
roups (mean 64% in both), the post-exercise ejection
raction by gated imaging was lower in the ischemic than in
he nonischemic group (51.8% vs. 57.8%). A plausible
xplanation for this observation is that the post-exercise
jection fractions are lower in the ischemic group precisely
ecause of induced ischemia, because wall motion abnor-
alities are known to persist for a period of time after an
pisode of ischemia, a finding consistent with the study
ypothesis.
esting peptide levels. An unexpected finding was that
edian levels of both NT-pro-BNP and BNP were signif-cantly higher at rest in the group of patients with inducible mschemia than in the group without (Table 2). However, a
ecent study (30) of over 300 patients measured BNP levels
n patients with known CAD and found similar elevations
n resting levels in those patients with inducible ischemia on
maging studies, compared with those without, corroborat-
ng our observation. If, as our findings suggest, ischemia
riggers the release of these natriuretic peptides, patients
ith ischemia on scans may have higher baseline levels of
T-pro-BNP and BNP because of chronic or recurrent
pisodes of ischemia before testing. Our ischemic group
ontained patients with evidence of myocardial scar on
erfusion imaging; however, it is not likely that this ac-
ounts for the increase in resting peptide levels in this group,
ecause, as previously noted, a subset analysis that excluded
hese patients showed resting levels not significantly differ-
nt from the ischemic group as a whole (Table 4). The
igher age of the ischemic group compared with the
onischemic group also does not account for the differences
n baseline levels, because both groups fall within the same
ecile of age for normal ranges.
xercise ECGs. An additional unexpected finding was
hat the ischemic and nonischemic groups did not differ in
he percent of patients with abnormal exercise ECGs. The
ensitivity of the ECG for detecting ischemia in our patients
37.5%) was in the lower range of those commonly reported
or exercise testing. However, most studies of exercise
esting have examined the ability of the exercise ECG to
etect coronary stenosis on angiography and are affected by
orkup bias, which tends to overestimate sensitivity (1); our
esults are similar to those reported for the few published
tudies with reduced workup bias (2,3). Only a small
umber of studies have examined the ability of the exercise
CG to predict reversible defects on nuclear imaging; two
epresentative studies (31,32) compared ECG findings with
erfusion images and found ECG sensitivities of 45.5% and
2.8%, which are similar to the findings in our patients. In
ddition, a recent study (33) of over 700 patients found the
ensitivity of the exercise ECG for detecting ischemia on
yocardial imaging to be 36.6% to 40.0%, a range that
ncludes the value found in our study.
In clinical practice, it is common to interpret as “indeter-
inate” exercise ECGs with no abnormal changes but a
able 6. Specificity of NTproBNP in Nonischemic Patients
Cutoff Point
(pg/ml)
Nonischemic
Group
Normal
Volunteers
5 0.59 0.57
6 0.71 0.57
7 0.71 0.71
8 0.74 0.71
9 0.74 0.76
10 0.82 0.76
11 0.82 0.81
12 0.85 0.85
NT-pro-BNP  post-exercise change in N-terminal fragment of B-type natriuretic
eptide pro-hormone.aximal heart rate 85% of predicted maximum, on the
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nduce ischemia, particularly in territories supplied by arter-
es with only moderate stenosis. However, because all
atients in our study underwent myocardial perfusion im-
ging, we knew in all cases whether ischemia was present,
nd thus we considered ECGs with no diagnostic changes
or ischemia to be negative regardless of the maximal heart
ate achieved; if ischemia was present and the ECG failed to
etect it, the ECG was falsely negative.
se of BNPs to detect ischemia. Our findings suggest
hat an exercise-induced rise in BNP levels is a marker of
nducible ischemia, and in our patients it was considerably
ore accurate in the detection of ischemia than was
T-segment depression on exercise electrocardiography.
omparative test characteristics of ECG findings and
NT-pro-BNP and BNP levels for the detection of
schemia, set at equal specificities to the ECG, are shown in
able 7. Compared with the ECG, measurement of NT-
ro-BNP and BNP more than doubled the sensitivity of
he exercise test for ischemia (NT-pro-BNP 90%, BNP
0%; ECG 37.5%) with no loss of specificity. NT-pro-
NP, in particular, correctly predicted the presence or
bsence of ischemia almost twice as frequently as the ECG
diagnostic accuracy 75.7% vs. 47.3%).
Additionally, the presence in our study of two groups
ithout ischemia, the nonischemic patients and healthy
olunteers, provided the opportunity to compare the spec-
ficity of NT-pro-BNP values at various cutoff points in
hese groups (Table 6). Although the numbers are small,
his comparison suggests that the rate of true negative
NT-pro-BNP results at any given cutoff point is consis-
ent in two populations with markedly different ages, clinical
haracteristics, resting NT-pro-BNP levels, and exercise
apacities.
Reduced regional myocardial blood flow results in a
ascade of changes beginning with relaxation failure and
rogressing to contraction abnormalities, rise in filling
ressure, ECG changes, and finally symptoms (34). Because
CG abnormalities occur later in this process than changes
n ventricular wall function, this may explain why BNPs
ould rise before ECG abnormalities appear; in other
ords, measuring NT-pro-BNP or BNP rise may be more
ensitive because it detects reduced myocardial blood flow at
n earlier stage.
onclusions. In summary, our findings suggest that
able 7. Test Characteristics of BNP, NTproBNP, and ECG
Sensitivity Specificity
P
NT-pro-BNP 5 pg/ml 90.0% 58.8%
BNP 10 pg/ml 80.0% 58.8%
1-mm ST depression on ECG 37.5% 58.8%
BNP  post-exercise change in brain natriuretic peptide (carboxy-terminal active fra
ragment of brain natriuretic peptide pro-hormone.xercise-induced ischemia or its associated regional wallotion abnormalities trigger release of BNPs and that
easurement of plasma levels of NT-pro-BNP and BNP
efore and immediately after symptom-limited exercise can
istinguish patients with and without ischemia, defined as
eversible defects on radionuclide imaging, with a high
egree of accuracy. In our group of patients with known
AD, the ability of BNP and NT-pro-BNP to detect
schemia was considerably better than that of the exercise
CG (90% vs. 37.5%) and distinguished between ischemic
nd nonischemic patients nearly twice as accurately as the
xercise ECG. Assays for these peptides are relatively
nexpensive and precise; in addition, NT-pro-BNP, al-
hough not BNP, is stable in whole blood for at least 48 h
24,35), and thus special handling is not required.
Measurement of these markers before and after exercise
ffers the potential for a substantial increase in the diagnos-
ic accuracy of exercise testing.
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